2016-08-19 13:39:32 UTC

Free On-Demand CME for Treating Patients with IBD or HCV

Aug. 23, 2016

Learn how to bridge gaps across payor and provider settings through a free online, on-demand program offering CME.

Learn how to bridge gaps and make better treatment and policy decisions for patients with HCV or IBD. Payer and Provider Discussions to Overcome Barriers in Evidence-Based Treatment Decisions in HCV and IBD is a free online, on-demand program offering 1.0 AMA PRA Category 1 Credit™. 

This unique program, planned in conjunction with AGA and the Academy of Managed Care Pharmacy (AMCP), engaged gastroenterologists and managed care decision makers in collaborative learning and problem solving during live meetings across the U.S.

 Experts in HCV, IBD and managed care pharmacy led participants in discussing the latest clinical evidence and identifying strategies to improve interprofessional communication, navigate managed care requirements and leverage resources to improve patient outcomes.The webcast of the presentation captured these discussions that reflect the most relevant and challenging issues faced by health-care professionals in making treatment and policy decisions for patients with HCV or IBD. Watch the webcast now

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.